Jan-Aug sales at BioMaxima up 88% as company enters Switzerland
10 years 34 weeks atpakaļ
PCZ’s drug wholesaling unit receives additional GIF permit
10 years 34 weeks atpakaļ
Bioton reports 23% rise in like-for-like sales in H1 thanks to strong insulin sales
10 years 34 weeks atpakaļ
Swissmed partners with AHP
10 years 34 weeks atpakaļ
Inno-Gene posts dynamic sales growth in Q2 as new ventures prepare to start operations
10 years 35 weeks atpakaļ
OTC market in CIS countries 2013
10 years 36 weeks atpakaļ
Ministry unveils new reimbursement lists
10 years 36 weeks atpakaļ
Ministry outlines changes to Reimbursement Act
10 years 37 weeks atpakaļ
Hebe to enter Katowice market
10 years 38 weeks atpakaļ
Biological and biosimilars drug market in Poland 2013
10 years 38 weeks atpakaļ
SUKL to apply new guidelines on examination of MA variations
10 years 38 weeks atpakaļ
Egis reports sales of €13.6m in Poland in April-June 2013
10 years 38 weeks atpakaļ
EI exits Magellan
10 years 38 weeks atpakaļ
ERROR: Tried to load source page, but remote server reported "503 Service Unavailable".
10 years 38 weeks atpakaļ
BioMaxima posts strong Q2 results, expects to complete new M&A deals in Q3
10 years 38 weeks atpakaļ
Private healthcare market in CIS countries 2013
10 years 39 weeks atpakaļ
Further increase in number of real users of Doz.pl in April 2013
10 years 39 weeks atpakaļ
Pharmena announces positive findings from 1-MNA supplement study
10 years 40 weeks atpakaļ
Swissmed to open talks with new investor as equity sale to LUX MED Group collapses
10 years 40 weeks atpakaļ
Dr. Max launches first drug under its brand name in the Czech Republic
10 years 40 weeks atpakaļ
- « pirmais
- ‹ iepriekšējais
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- …
- nākamais ›
- pēdējais »